Phase II Trial Of Combretastatin A-4 Phosphate (CA4P) In Advanced Anaplastic Carcinoma Of The Thyroid
Phase of Trial: Phase II
Latest Information Update: 16 Mar 2010
At a glance
- Drugs Fosbretabulin (Primary)
- Indications Thyroid cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 17 Mar 2009 Results available, as reported in a media release from OXiGENE.
- 06 Feb 2008 Status change from in progress to completed.